Cancer Immunotherapy Explained: PD-1, PD-L1, CTLA-4, Checkpoint Inhibitors and Immune Side Effects

Understand Your Guide to Immunotherapy with a focused overview of cancer immunotherapy, immune checkpoint inhibitors, and PD-1 PD-L1 blockade. Important topics include CTLA-4 inhibitors, immune related adverse events, and immuno-oncology, with practical context for diagnosis, treatment sequencing, expected outcomes, and follow-up. The video is especially relevant to people searching for cancer immunotherapy, CTLA-4 inhibitors, or immune related adverse events and wanting a clearer explanation of how oncologists make treatment decisions. Designed to clarify complex oncology terminology and support informed conversations about diagnosis, treatment, and follow-up. Follow-up may include clinical review blood tests imaging or surveillance based on disease type. Treatment